Same Indication

Ipilimumab vs Trimethoprim

Ipilimumab vs Trimethoprim: Overview

This comparison examines the pharmacological differences between Ipilimumab and Trimethoprim.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Trimethoprim: Dihydrofolate reductase inhibitor (bacterial selective).

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Trimethoprim — 8-10 hours.

Chemical Properties

Molecular Formula: Trimethoprim — C14H18N4O3.

Molecular Weight: Trimethoprim — 290.3180 g/mol.

Type: Ipilimumab — Antibody; Trimethoprim — Small molecule.